Dr. Laurens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-706-5328Fax+1 410-706-1204
Summary
- Dr. Matthew Laurens is a pediatric infectious disease specialist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and University of Maryland Upper Chesapeake Medical Center. He received his medical degree from Mercer University School of Medicine and has been in practice 16 years. He specializes in pediatrics, pediatric travel and tropical medicine, and pediatric vaccinology and vaccine preventable diseases and is experienced in pediatric infectious disease.
Education & Training
- University of MarylandFellowship, Pediatric Infectious Diseases, 2005 - 2008
- Tulane UniversityResidency, Pediatrics, 2001 - 2005
- Mercer University School of MedicineClass of 2001
Certifications & Licensure
- MD State Medical License 2005 - 2026
- LA State Medical License 2002 - 2006
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine Start of enrollment: 2019 Jul 08
Publications & Presentations
PubMed
- 37 citationsExtended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial.Matthew B. Laurens, Mahamadou A. Thera, Drissa Coulibaly, Amed Ouattara, Abdoulaye K. Kone
Plos One. 2013-11-18 - 13 citationsPfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.Drissa Coulibaly, Abdoulaye K Kone, Karim Traore, Amadou Niangaly, Bourema Kouriba
Eclinicalmedicine. 2022-10-01 - 212 citationsRTS,S/AS01 vaccine (Mosquirix™): an overviewMatthew B. Laurens
Human Vaccines & Immunotherapeutics. 2020-03-03
Press Mentions
- Extra Spring COVID Boosters Cleared for Some Americans | HealthApril 21st, 2023
- Extra COVID-19 Booster Now Open to Some High-Risk AmericansApril 20th, 2023
- FDA Clears Extra COVID Booster for Some High-Risk AmericansApril 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: